These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.
    Author: Schulz G, Bumol TF, Reisfeld RA.
    Journal: Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5407-11. PubMed ID: 6577434.
    Abstract:
    Monoclonal antibody 9.2.27 (mAb 9.2.27) directed to a chondroitin sulfate proteoglycan on human melanoma cells was able to suppress tumor growth in athymic (nu/nu) mice more effectively when bound with polyethylene glycol to murine effector cells than when injected alone. These "armed" effector cells also proved more effective than the monoclonal antibody in eliciting antibody-dependent cellular cytotoxicity against human melanoma target cells in vitro.
    [Abstract] [Full Text] [Related] [New Search]